Abstract：Objective To summarize the clinical characteristics and genetic variations in children with cystic fibrosis (CF) primarily presenting with pseudo-Bartter syndrome (CF-PBS), with the aim to enhance understanding of this disorder. Methods A retrospective analysis was performed on the clinical data of three children who were diagnosed with CF-PBS in Hunan Children's Hospital from January 2018 to August 2023, and a literature review was performed. Results All three children had the onset of the disease in infancy. Tests after admission showed hyponatremia, hypokalemia, hypochloremia, and metabolic alkalosis, and genetic testing showed the presence of compound heterozygous mutation in the CFTR gene. All three children were diagnosed with CF. Literature review obtained 33 Chinese children with CF-PBS, with an age of onset of 1-36 months and an age of diagnosis of 3-144 months. Among these children, there were 29 children with recurrent respiratory infection or persistent pneumonia (88%), 26 with malnutrition (79%), 23 with developmental retardation (70%), and 18 with pancreatitis or extrapancreatic insufficiency (55%). Genetic testing showed that c.2909G>A was the most common mutation site of the CFTR gene, with a frequency of allelic variation of 23% (15/66). Conclusions CF may have no typical respiratory symptoms in the early stage. The possibility of CF-PBS should be considered for infants with recurrent hyponatremia, hypokalemia, hypochloremia, and metabolic alkalosis, especially those with malnutrition and developmental retardation. CFTR genetic testing should be performed as soon as possible to help with the diagnosis of CF.
ZHANG Ji-Yan,SUN Lin-Jun,DUAN Xiao-Jun et al. Cystic fibrosis primarily presenting with pseudo-Bartter syndrome: a report of three cases and literature review[J]. CJCP, 2024, 26(5): 506-511.
Mantoo MR, Kabra M, Kabra SK. Cystic fibrosis presenting as pseudo-Bartter syndrome: an important diagnosis that is missed![J]. Indian J Pediatr, 2020, 87(9): 726-732. PMID: 32504456. DOI: 10.1007/s12098-020-03342-8.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. PMID: 25741868. PMCID: PMC4544753. DOI: 10.1038/gim.2015.30.
Qiu L, Yang F, He Y, et al. Clinical characterization and diagnosis of cystic fibrosis through exome sequencing in Chinese infants with Bartter-syndrome-like hypokalemia alkalosis[J]. Front Med, 2018, 12(5): 550-558. PMID: 29520692. DOI: 10.1007/s11684-017-0567-y.
Shen Y, Tang X, Liu J, et al. Pseudo-Bartter syndrome in Chinese children with cystic fibrosis: clinical features and genotypic findings[J]. Pediatr Pulmonol, 2020, 55(11): 3021-3029. PMID: 32761997. DOI: 10.1002/ppul.25012.
Villanueva G, Marceniuk G, Murphy MS, et al. Diagnosis and management of cystic fibrosis: summary of NICE guidance[J]. BMJ, 2017, 359: j4574. PMID: 29074599. DOI: 10.1136/bmj.j4574.
La Bella S, Fiorentino R, Carabotta M, et al. A difficult case of hyponatremic and hypokalemic metabolic alkalosis: answers[J]. Pediatr Nephrol, 2022, 37(12): 3065-3067. PMID: 35579758. DOI: 10.1007/s00467-022-05610-5.
Sismanlar Eyuboglu T, Dogru D, ?ak?r E, et al. Clinical features and accompanying findings of pseudo-Bartter syndrome in cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(8): 2011-2016. PMID: 32364312. DOI: 10.1002/ppul.24805.
Levento?lu E, Kenan BU, ?ak?r EP, et al. Chronic cough in an adolescent with infantile onset of hypokalemic hypochloremic metabolic alkalosis: answers[J]. Pediatr Nephrol, 2023, 38(4): 1029-1031. PMID: 35723735. DOI: 10.1007/s00467-022-05647-6.
Shi R, Wang X, Lu X, et al. A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis[J]. Pediatr Pulmonol, 2020, 55(11): 3005-3011. PMID: 32716133. DOI: 10.1002/ppul.24980.
Shen Y, Tang X, Chen Q, et al. Genetic spectrum of Chinese children with cystic fibrosis: comprehensive data analysis from the main referral centre in China[J]. J Med Genet, 2022, 60(3): 310-315. PMID: 35858753. PMCID: PMC9985745. DOI: 10.1136/jmg-2022-108501.
Clain J, Fritsch J, Lehmann-Che J, et al. Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function[J]. J Biol Chem, 2001, 276(12): 9045-9049. PMID: 11118444. DOI: 10.1074/jbc.M008979200.
Macek M, Hamosh A, Kiesewetter S, et al. Identification of a novel nonsense mutation (L88X) in exon 3 of the cystic fibrosis transmembrane conductance regulator gene in a native Korean cystic fibrosis chromosome[J]. Hum Mutat, 1992, 1(6): 501-502. PMID: 1284542. DOI: 10.1002/humu.1380010608.
Abdul Aziz D, Siddiqui F, Abbasi Q, et al. Characteristics of electrolyte imbalance and pseudo-Bartter syndrome in hospitalized cystic fibrosis children and adolescents[J]. J Cyst Fibros, 2022, 21(3): 514-518. PMID: 34610890. DOI: 10.1016/j.jcf.2021.09.013.
